NY EMS protocol directory
Check the state listing and local adoption before selecting a protocol. The current collaborative listing is v26.2, effective September 11, 2026.
Source checked 2026-10-07Verified source library
25 primary-source references for protocols, medication safety, pediatrics, resuscitation and study planning.
Checked October 7, 2026. Follow the protocol adopted by your agency and your provider scope. National guidance and product labeling help interpret care; they do not automatically replace local orders. External documents need internet. This directory is available offline after the app cache updates.
25 resources
Check the state listing and local adoption before selecting a protocol. The current collaborative listing is v26.2, effective September 11, 2026.
Source checked 2026-10-07Current collaborative protocol PDF. MedMath also includes an offline copy and updated contents index.
Source checked 2026-10-07Official source for the currently posted ALS, IALS and BLS documents, scope and medication lists.
Source checked 2026-10-07Paramedic pathways, pediatric dosing, eligibility and medical-command requirements.
Source checked 2026-10-07AEMT pathways and dose charts. ALS medication availability does not establish AEMT scope.
Source checked 2026-10-07BLS assessment, treatment, transport and ALS-assistance pathways.
Source checked 2026-10-07Official downloads for adult, pediatric and neonatal resuscitation. Check the edition printed on each aid.
Source checked 2026-10-072025 recommendations and supporting evidence for pediatric resuscitation.
Source checked 2026-10-072025 adult arrest and peri-arrest guidance, including shockable rhythms.
Source checked 2026-10-072025 newborn transition and resuscitation guidance; effective ventilation is central.
Source checked 2026-10-072025 guidance for selected toxicologic, environmental and other special circumstances.
Source checked 2026-10-07AirLife confirms the 2026 edition, revision 4. This product listing does not provide the complete medication tables.
Source checked 2026-10-07Manufacturer instructions explain weight/length selection and equipment considerations. The public instructions do not reproduce the full 2026 dose and equipment tables.
Source checked 2026-10-07Agency readiness resources covering equipment, education, policies and quality improvement.
Source checked 2026-10-07Dosing-safety resources and example tools. Examples from other jurisdictions require local adaptation and approval.
Source checked 2026-10-072024 checklist for reviewing agency readiness and identifying gaps.
Source checked 2026-10-07Look up the exact formulation, strength, route and manufacturer. A label and an EMS protocol serve different purposes.
Source checked 2026-10-07FDA recommends deep IM administration; IV use requires the updated dilution and infusion instructions because of severe tissue-injury risk.
Source checked 2026-10-07Exposure assessment and diagnostic limitations, including why standard pulse oximetry cannot rule out CO poisoning.
Source checked 2026-10-072021 national field-triage resources. Apply the destination rules adopted by your EMS system.
Source checked 2026-10-07Current terminology and policy context for severe agitation; supports replacing the older excited-delirium label.
Source checked 2026-10-07Official examination information to guide study planning. It does not authorize clinical treatment.
Source checked 2026-10-07Official AEMT examination information and preparation context.
Source checked 2026-10-07National education framework for mapping learning objectives and finding content gaps.
Source checked 2026-10-07Model guidelines, version 3 (2022), for comparison and system development; they are not local standing orders.
Source checked 2026-10-07Targeted comparison corrected 23 medication topics in the paramedic deck and applied 11 AEMT-specific summaries. Corrections include pediatric albuterol, adenosine ceilings, separate adult/pediatric procainamide regimens, TXA eligibility, route restrictions and medical-command branches. Sources appear on the affected study cards.
PA ALS contains conflicting pediatric ondansetron and IM midazolam language, and an inconsistent calcium-chloride unit in the toxicology section. These conflicts are identified rather than resolved by guessing. Use the complete pathway and medical command for clarification.
AirLife confirms Broselow 2026 revision 4 and publishes instructions for use. The complete 2026 medication/equipment tables have not been verified. MedMath continues to label the supplied GMVEMSC 2025 sheet separately.
This comparison does not certify every legacy quiz, supplemental deck or clinical claim. Agency scope, patient assessment, contraindications, exact products and medical-command requirements still apply.